Schonfeld Strategic Advisors’s Bicycle Therapeutics BCYC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-42,500
| Closed | -$595K | – | 2072 |
|
|
2024
Q4 | $595K | Sell |
42,500
-380,500
| -90% | -$5.33M | ﹤0.01% | 1262 |
|
|
2024
Q3 | $9.57M | Buy |
423,000
+265,562
| +169% | +$6.01M | 0.06% | 252 |
|
|
2024
Q2 | $3.19M | Sell |
157,438
-263,362
| -63% | -$5.33M | 0.02% | 607 |
|
|
2024
Q1 | $10.5M | Buy |
420,800
+313,800
| +293% | +$7.81M | 0.07% | 324 |
|
|
2023
Q4 | $1.93M | Buy |
107,000
+54,900
| +105% | +$993K | 0.01% | 749 |
|
|
2023
Q3 | $1.05M | Sell |
52,100
-14,000
| -21% | -$281K | 0.01% | 889 |
|
|
2023
Q2 | $1.69M | Buy |
66,100
+6,000
| +10% | +$153K | 0.01% | 799 |
|
|
2023
Q1 | $1.28M | Sell |
60,100
-19,646
| -25% | -$418K | 0.01% | 845 |
|
|
2022
Q4 | $2.36M | Buy |
79,746
+58,946
| +283% | +$1.74M | 0.02% | 758 |
|
|
2022
Q3 | $483K | Sell |
20,800
-500
| -2% | -$11.6K | ﹤0.01% | 1748 |
|
|
2022
Q2 | $358K | Buy |
21,300
+13,300
| +166% | +$224K | ﹤0.01% | 1479 |
|
|
2022
Q1 | $351K | Buy |
+8,000
| New | +$351K | ﹤0.01% | 1521 |
|
|
2021
Q4 | – | Sell |
-59,972
| Closed | -$2.49M | – | 1978 |
|
|
2021
Q3 | $2.49M | Buy |
59,972
+5,110
| +9% | +$213K | 0.03% | 588 |
|
|
2021
Q2 | $1.67M | Buy |
54,862
+43,762
| +394% | +$1.33M | 0.02% | 735 |
|
|
2021
Q1 | $331K | Buy |
+11,100
| New | +$331K | ﹤0.01% | 1257 |
|